Brief: The Pancreatic Cancer Action Network Selects Oncolytics Biotech Inc. To Receive $5 Million Therapeutic Accelerator Award To Develop Leading-Edge Treatments
26/09/2023 12:20
Sept 26 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS
BIOTECH®
INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO
DEVELOP LEADING-EDGE TREATMENTS
Source text for Eikon: ID:nPrelsgvHa
Further company coverage: ONC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer